BEDFORD, Mass.--(BUSINESS WIRE)--Access Vascular, Inc. today announced FDA clearance of its HydroMID™ midline catheter. HydroMID, which is made of Access Vascular’s proprietary biomaterial that has ...

BILLERICA, Mass.--(BUSINESS WIRE)--Access Vascular, Inc. (AVI), a leader in tackling critical vascular access challenges with its advanced hydrophilic biomaterial technology, today announced findings ...

MINNEAPOLIS, April 28, 2026 (GLOBE NEWSWIRE)-- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company committed to delivering solutions for patients with cardiorenal conditions, announces that ...

Hope is on the horizon for sick children requiring intravenous canulation to administer medication. A Griffith University–led randomized controlled trial has provided evidence about the most effective ...

In a large retrospective analysis, midline catheters were associated with markedly lower risk of bloodstream infection and occlusion compared with peripherally inserted central catheters (PICCs). Data ...

Access Vascular Inc.’s biomaterial-based catheters aim to address complication rates that have long plagued the space. Vascular access complications delay treatment, incur additional risk for patients ...

The incidence of catheter-related bloodstream infections was low in patients with midline vs peripherally inserted central catheters, but the use of midline catheters was associated with increased ...

The FDA granted Teleflex ($TFX) 510(k) clearance to begin marketing its Arrow Midline with Chlorag+ard technology for use in the U.S. market. The device is an ...

The objective of this study is to compare complication rates between peripherally inserted central catheters (PICCs) and peripherally inserted non-central catheters (PINCCs) in the neonatal intensive ...

DELRAY BEACH, Fla., Feb. 21, 2025 /PRNewswire/ -- The global vascular access devices market, valued at US$5.60 billion in 2023, is forecasted to grow at a robust CAGR of 7.1%, reaching US$5.99 billion ...